Profit Margin (Annual)

Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues

MDxHealth SA (MDXH) had Profit Margin of -31.07% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$107.88M
Net Income	$-33.52M
Cost of Goods Sold	$38.24M
Gross Profit	$69.63M
Operating Expenses	$122.28M
Operating Income	$-14.41M
Non-Operating Income/Expense	$-20.97M
Pre-Tax Income	$-35.38M
Normalized Pre-Tax Income	$-35.38M
Income after Taxes	$-33.52M
Income from Continuous Operations	$-33.52M
Consolidated Net Income/Loss	$-33.52M
Normalized Income after Taxes	$-33.52M
EBIT	$-14.41M
EBITDA	$-5.20M
Weighted-Average Shares Outstanding (Basic)	49.96M
Weighted-Average Shares Outstanding (Diluted)	49.96M
Earnings per Share (EPS) (Basic)	$-0.67
Earnings per Share (EPS) (Diluted)	$-0.67
Balance Sheet Financials
Current Assets	$53.41M
Property, Plant, and Equipment	$4.86M
Long-Term Assets	$94.54M
Total Assets	$147.95M
Current Liabilities	$49.53M
Long-Term Debt	$84.71M
Long-Term Liabilities	$110.51M
Total Liabilities	$160.05M
Common Equity	$-12.09M
Tangible Shareholders Equity	$-90.47M
Shareholders Equity	$-12.09M
Common Shares Outstanding	51.37M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.19M
Cash Flow from Investing Activities	$-18.56M
Cash Flow from Financial Activities	$2.96M
Beginning Cash	$46.80M
End Cash	$29.03M
Increase/Decrease in Cash	$-17.77M
Stock-Based Compensation	$2.21M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.08
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.17
Debt to Equity Ratio	-7.16
Gross Margin	64.55%
Operating Margin	-13.36%
EBIT Margin	-13.36%
EBITDA Margin	-4.82%
Pre-Tax Profit Margin	-32.79%
Profit Margin	-31.07%
Free Cash Flow	$-3.35M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.73
Inventory Turnover	5.67
Receiveable Turnover	7.35
Days Sales in Receivables	49.65
Return on Equity	277.15%
Return on Tangible Equity	37.05%
Return on Assets	-22.66%
Return on Investments	-46.16%
Book Value Per Share	$-0.24
Free Cash Flow per Share	$-0.07
Operating Cash Flow per Share	$-0.04

Data from Zacks Investment Research, Inc.